Skip to main content
Top
Published in: Journal of Endocrinological Investigation 10/2017

01-10-2017 | Original Article

Physical performance in newly diagnosed hypothyroidism: a pilot study

Authors: D. Gallo, E. Piantanida, G. Veronesi, A. Lai, L. Sassi, V. Lombardi, E. Masiello, P. Premoli, E. Bianconi, C. Cusini, S. Rosetti, M. L. Tanda, A. Toniolo, M. Ferrario, L. Bartalena

Published in: Journal of Endocrinological Investigation | Issue 10/2017

Login to get access

Abstract

Objective

Hypothyroidism is complicated by neuromuscular symptoms (myalgias, slowness of movements, and tiredness) and signs (easy fatigability and cramps), which may have a negative impact on general well-being and quality of life. In a pilot, prospective, controlled study, we investigated the features of muscle dysfunction in hypothyroidism by disease questionnaire, biochemical measures, and physical performance tests.

Materials and Methods

Fifty-seven consecutive patients with newly diagnosed hypothyroidism were enrolled, 27 subclinical (S-Hypo) and 30 overt (O-Hypo). A series of 30 euthyroid subjects, with similar demographic characteristics, served as controls. Patients were administered a short disease questionnaire and underwent laboratory exams and standardized physical tests, both at baseline and after restoration of biochemical euthyroidism.

Results

Compared to euthyroid controls, the O-Hypo group showed significantly higher prevalence of neuromuscular symptoms and significantly higher serum creatine phosphokinase (CPK) levels (p value < 0.0001). S-Hypo had slightly higher CPK levels and prevalence of neuromuscular symptoms than controls. Both S-Hypo and O-Hypo patients performed worse than controls in the six-minute walking test. Differences between patients and controls in handgrip strength test and timed chair standing test failed to reach statistical significance (although a trend was noticeable), possibly due to the small sample size. In O-Hypo, an inverse correlation was found between CPK levels and the handgrip strength test (p value < 0.001). Restoration of euthyroidism was associated with normalization of questionnaire responses, six-minute walking test, as well as serum CPK levels.

Conclusion

In addition to neuromuscular symptoms, hypothyroidism is associated with abnormalities of physical performance. The six-minute walking test is the most valuable test to assess this aspect. In the pilot study, levothyroxine therapy could reverse muscle functional abnormalities.
Literature
1.
go back to reference Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL (2013) ETA guidelines: management of subclinical hypothyroidism. Eur Thyroid J 2 (15): 215–228CrossRefPubMedPubMedCentral Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL (2013) ETA guidelines: management of subclinical hypothyroidism. Eur Thyroid J 2 (15): 215–228CrossRefPubMedPubMedCentral
2.
go back to reference Watt T, Cramon P, Hegedüs L, Bjorner JB, Bonnema SJ, Rasmussen ÅK, Feldt-Rasmussen U, Groenvold M (2014) The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab 99(10):3708–3717CrossRefPubMed Watt T, Cramon P, Hegedüs L, Bjorner JB, Bonnema SJ, Rasmussen ÅK, Feldt-Rasmussen U, Groenvold M (2014) The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab 99(10):3708–3717CrossRefPubMed
3.
go back to reference Vigário P, Teixeira P, Reuters V, Almeida C, Maia M, Silva M, Vaisman M (2009) Perceived health status of women with overt and subclinical hypothyroidism. Med Princ and Pract 18:317–322 Vigário P, Teixeira P, Reuters V, Almeida C, Maia M, Silva M, Vaisman M (2009) Perceived health status of women with overt and subclinical hypothyroidism. Med Princ and Pract 18:317–322
4.
go back to reference Rhee CM, Curhan GC, Alexander EK, Bhan I, Brunelli SM (2013) Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab 98(6):2326–2336CrossRefPubMedPubMedCentral Rhee CM, Curhan GC, Alexander EK, Bhan I, Brunelli SM (2013) Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab 98(6):2326–2336CrossRefPubMedPubMedCentral
6.
7.
go back to reference de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijis HC, Kramer MH, Vandenbroucke JP, Dekkers OM (2011) Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 165(4):545–554CrossRefPubMed de Jongh RT, Lips P, van Schoor NM, Rijs KJ, Deeg DJ, Comijis HC, Kramer MH, Vandenbroucke JP, Dekkers OM (2011) Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 165(4):545–554CrossRefPubMed
8.
go back to reference Lankahaar JAC, de Vries WR, Jansen JACG, Zelissen PMJ, Backx FJG (2014) Impact of overt and subclinical hypothyroidism on exercise tolerance: a systematic review. Res Q Exerc Sport 85(3):365–389CrossRef Lankahaar JAC, de Vries WR, Jansen JACG, Zelissen PMJ, Backx FJG (2014) Impact of overt and subclinical hypothyroidism on exercise tolerance: a systematic review. Res Q Exerc Sport 85(3):365–389CrossRef
9.
go back to reference Caraccio N, Natali A, Sironi A, Baldi S, Frascerra S, Dardano A, Monzani F, Ferrannini E (2005) Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial with levothyroxine. J Clin Endocrinol Metab 90(7):4057–4062CrossRefPubMed Caraccio N, Natali A, Sironi A, Baldi S, Frascerra S, Dardano A, Monzani F, Ferrannini E (2005) Muscle metabolism and exercise tolerance in subclinical hypothyroidism: a controlled trial with levothyroxine. J Clin Endocrinol Metab 90(7):4057–4062CrossRefPubMed
10.
go back to reference Shatynska-Mytsyk I, Rodrigo L, Cioccocioppo R Petrovic D, Lakusic N, Compostella L, Novak M, Kruzliak P (2016) The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism. J Endocrinol Invest 39(6):709–713CrossRefPubMed Shatynska-Mytsyk I, Rodrigo L, Cioccocioppo R Petrovic D, Lakusic N, Compostella L, Novak M, Kruzliak P (2016) The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism. J Endocrinol Invest 39(6):709–713CrossRefPubMed
11.
go back to reference Biondi B, Klein I (2004) Hypothyroidism as a risk factor for cardiovascular disease. Endocr 24(1):1–13CrossRef Biondi B, Klein I (2004) Hypothyroidism as a risk factor for cardiovascular disease. Endocr 24(1):1–13CrossRef
13.
go back to reference Piantanida E, Gallo D, Veronesi G, Pariani N, Masiello E, Premoli P, Sassi L, Lai A, Tanda ML, Ferrario M, Bartalena L (2016) Masked hypertension in newly diagnosed hypothyroidism: a pilot study. J Endocrinol Invest 39:1131–1138CrossRefPubMed Piantanida E, Gallo D, Veronesi G, Pariani N, Masiello E, Premoli P, Sassi L, Lai A, Tanda ML, Ferrario M, Bartalena L (2016) Masked hypertension in newly diagnosed hypothyroidism: a pilot study. J Endocrinol Invest 39:1131–1138CrossRefPubMed
14.
go back to reference Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WHJP (2000) Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psych 68:750–755CrossRef Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WHJP (2000) Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psych 68:750–755CrossRef
15.
go back to reference Monzani F, Caraccio N, Siciliano G, Manca L, Murri L, Ferrannini E (1997) Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 82(10):3315–3318CrossRefPubMed Monzani F, Caraccio N, Siciliano G, Manca L, Murri L, Ferrannini E (1997) Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 82(10):3315–3318CrossRefPubMed
16.
go back to reference Visser WE, Heemstra KA, Swagemakers SM, Ozgür Z, Corssmit EP, Burggraaf J, van Ijcken WF, van der Spek PJ, Smit JW, Visser TJ (2009) Physiological thyroid hormone levels regulate skeletal muscle transcripts. J Clin Endocrinol Metab 94(9):3487–3496CrossRefPubMed Visser WE, Heemstra KA, Swagemakers SM, Ozgür Z, Corssmit EP, Burggraaf J, van Ijcken WF, van der Spek PJ, Smit JW, Visser TJ (2009) Physiological thyroid hormone levels regulate skeletal muscle transcripts. J Clin Endocrinol Metab 94(9):3487–3496CrossRefPubMed
17.
go back to reference Salvatore D (2014) Thyroid Hormones and skeletal muscle—new insights and potential implications. Nat Rev Endocrinol 10(4):206–214CrossRefPubMed Salvatore D (2014) Thyroid Hormones and skeletal muscle—new insights and potential implications. Nat Rev Endocrinol 10(4):206–214CrossRefPubMed
18.
go back to reference Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endocrinol (Oxf) 1999; 51 (2): 237–242CrossRef Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endocrinol (Oxf) 1999; 51 (2): 237–242CrossRef
19.
go back to reference Simonides WS, van Hardeveid C (2008) Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 18(2):205–216CrossRefPubMed Simonides WS, van Hardeveid C (2008) Thyroid hormone as a determinant of metabolic and contractile phenotype of skeletal muscle. Thyroid 18(2):205–216CrossRefPubMed
20.
go back to reference Lombardi A, De Matteis R, Moreno M, Napolitano L, Busiello RA, Senese R, de Lange P, Lanni A, Goglia F (2012) Responses of skeletal muscle lipid metabolism in rat gastrocnemius and iodothyronine administration: a putative role for FAT/CD36. Am J Physiol Endocrinol Metab 303:E1222–E1233CrossRefPubMed Lombardi A, De Matteis R, Moreno M, Napolitano L, Busiello RA, Senese R, de Lange P, Lanni A, Goglia F (2012) Responses of skeletal muscle lipid metabolism in rat gastrocnemius and iodothyronine administration: a putative role for FAT/CD36. Am J Physiol Endocrinol Metab 303:E1222–E1233CrossRefPubMed
21.
go back to reference Magri F, Buoncuore M, Oliviero A, Rotondi M, Gatti A, Accornero S, Camera A, Chiovato L (2010) Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. Eur J Endocrinol 163:279–284CrossRefPubMed Magri F, Buoncuore M, Oliviero A, Rotondi M, Gatti A, Accornero S, Camera A, Chiovato L (2010) Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. Eur J Endocrinol 163:279–284CrossRefPubMed
22.
go back to reference Khaleeli AA, Griffith DG, Edwards RH (1983) The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle. Clin Endocrinol (Oxf) 19:365–367CrossRef Khaleeli AA, Griffith DG, Edwards RH (1983) The clinical presentation of hypothyroid myopathy and its relationship to abnormalities in structure and function of skeletal muscle. Clin Endocrinol (Oxf) 19:365–367CrossRef
23.
go back to reference Winther KH, Cramon P, Watt T, Bjorner JB, Ekholm O, Feldt-Rasmussen U, Groenvold M, Rasmussen ÅK, Hegedüs L, Bonnema SJ (2016) Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS One 11(6):0156925CrossRef Winther KH, Cramon P, Watt T, Bjorner JB, Ekholm O, Feldt-Rasmussen U, Groenvold M, Rasmussen ÅK, Hegedüs L, Bonnema SJ (2016) Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS One 11(6):0156925CrossRef
24.
go back to reference Mainenti MR, Vigário PS, Teixeira PF, Maia MD, Oliveira FP, Vaisman M (2009) Effect of levothyroxine replacement on exercise performance in subclinical hypothyroidism. J Endocrinol Invest 32(5):470–473CrossRefPubMed Mainenti MR, Vigário PS, Teixeira PF, Maia MD, Oliveira FP, Vaisman M (2009) Effect of levothyroxine replacement on exercise performance in subclinical hypothyroidism. J Endocrinol Invest 32(5):470–473CrossRefPubMed
25.
go back to reference Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16(1):31–41CrossRefPubMed
26.
go back to reference Simeoni M, Cerantonio A, Pastore I, Liguori R, Greco M, Foti D, Gulletta E, Brunetti A, Fuiano G (2016) The correct renal function evaluation in patients with thyroid dysfunction. J Endocrinol Invest 39:495–507CrossRefPubMed Simeoni M, Cerantonio A, Pastore I, Liguori R, Greco M, Foti D, Gulletta E, Brunetti A, Fuiano G (2016) The correct renal function evaluation in patients with thyroid dysfunction. J Endocrinol Invest 39:495–507CrossRefPubMed
27.
go back to reference NHLBI Obesity Education Initiative. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health 2000; NIH Publication Number 00-4084 NHLBI Obesity Education Initiative. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. National Institutes of Health 2000; NIH Publication Number 00-4084
28.
go back to reference Schlussel MM, Dos Anjos LA, de Vasconcellos MT, Kac M (2008) References values of hand grip dynamometry of healthy adults: a population-based study. Clin Nutr 27:601–607CrossRefPubMed Schlussel MM, Dos Anjos LA, de Vasconcellos MT, Kac M (2008) References values of hand grip dynamometry of healthy adults: a population-based study. Clin Nutr 27:601–607CrossRefPubMed
29.
go back to reference Fess EE (1992) Grip strength. In: Casanova JS (ed) Clinical assessment recommendations, 2nd edn. American Society of Hand Therapists, Chicago, pp 41–45 Fess EE (1992) Grip strength. In: Casanova JS (ed) Clinical assessment recommendations, 2nd edn. American Society of Hand Therapists, Chicago, pp 41–45
30.
go back to reference Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB (2003) The 6-minute walking test: a quick measure of functional status in elderly adults. Chest 123(2):387–398CrossRefPubMed Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB (2003) The 6-minute walking test: a quick measure of functional status in elderly adults. Chest 123(2):387–398CrossRefPubMed
31.
go back to reference Faggiano P, D’Aloia A, Gualeni A, Brentano L, Dei Cas L (2004) The 6 min walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail 6:687–691CrossRefPubMed Faggiano P, D’Aloia A, Gualeni A, Brentano L, Dei Cas L (2004) The 6 min walking test in chronic heart failure: indications, interpretation and limitations from a review of the literature. Eur J Heart Fail 6:687–691CrossRefPubMed
32.
go back to reference Macfarlane DJ, Chou KL, Cheng HI, Chi I (2006) Validity and normative data for thirty-second chair stand test in elderly community - dwelling Hong Kong Chinese. Am J Hum Biol 18(3):418–421CrossRefPubMed Macfarlane DJ, Chou KL, Cheng HI, Chi I (2006) Validity and normative data for thirty-second chair stand test in elderly community - dwelling Hong Kong Chinese. Am J Hum Biol 18(3):418–421CrossRefPubMed
33.
34.
go back to reference Watt T, Hegedüs L, Groenvold M, Bjorner JB, Rasmussen ÅK, Bonnema SJ, Feldt-Rasmussen U (2010) Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 162:161–167CrossRefPubMed Watt T, Hegedüs L, Groenvold M, Bjorner JB, Rasmussen ÅK, Bonnema SJ, Feldt-Rasmussen U (2010) Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol 162:161–167CrossRefPubMed
35.
go back to reference Giampietro O, Clerico A, Buzzigoli G, Del Chicca MG, Boni C, Carpi A (1984) Detection of hypothyroid myopathy by measurement of various serum muscle markers–myoglobin, creatine kinase, lactate dehydrogenase and their isoenzymes. Correlation with thyroid hormone levels (free and total) and clinical usefulness. Horm Res 19(4):232–242CrossRefPubMed Giampietro O, Clerico A, Buzzigoli G, Del Chicca MG, Boni C, Carpi A (1984) Detection of hypothyroid myopathy by measurement of various serum muscle markers–myoglobin, creatine kinase, lactate dehydrogenase and their isoenzymes. Correlation with thyroid hormone levels (free and total) and clinical usefulness. Horm Res 19(4):232–242CrossRefPubMed
36.
go back to reference Khaleeli A, Gohil K, McPhail G, Round JR, Edwards R (1983) Muscle morphology and metabolism in hypothyroid myopathy: effects of treatment. J Clin Pathol 36:519–526CrossRefPubMedPubMedCentral Khaleeli A, Gohil K, McPhail G, Round JR, Edwards R (1983) Muscle morphology and metabolism in hypothyroid myopathy: effects of treatment. J Clin Pathol 36:519–526CrossRefPubMedPubMedCentral
37.
go back to reference McKeran RO, Ward P, Slavin G, Paul EA (1979) Central nuclear counts in muscle fibres before and during treatment in hypothyroid myopathy. J Clin Pathol 3(32):229–233CrossRef McKeran RO, Ward P, Slavin G, Paul EA (1979) Central nuclear counts in muscle fibres before and during treatment in hypothyroid myopathy. J Clin Pathol 3(32):229–233CrossRef
Metadata
Title
Physical performance in newly diagnosed hypothyroidism: a pilot study
Authors
D. Gallo
E. Piantanida
G. Veronesi
A. Lai
L. Sassi
V. Lombardi
E. Masiello
P. Premoli
E. Bianconi
C. Cusini
S. Rosetti
M. L. Tanda
A. Toniolo
M. Ferrario
L. Bartalena
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 10/2017
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-017-0661-7

Other articles of this Issue 10/2017

Journal of Endocrinological Investigation 10/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine